Anti-Angiogenic Effects of Ribonucleic Acid Interference Targeting Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor-1α
- 30 November 2007
- journal article
- research article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 144 (5), 761-768
- https://doi.org/10.1016/j.ajo.2007.07.022
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Intravitreal Triamcinolone Acetonide for Diabetic RetinopathyDevelopments in ophthalmology, 2007
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic RetinopathyOphthalmology, 2006
- Oxygen-dependent diseases in the retina: Role of hypoxia-inducible factorsExperimental Eye Research, 2006
- Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitroBritish Journal of Ophthalmology, 2006
- Erythropoietin Is Expressed in the Human Retina and It Is Highly Elevated in the Vitreous Fluid of Patients With Diabetic Macular EdemaDiabetes Care, 2006
- Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic IndividualsOphthalmology, 2006
- Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic RetinopathyNew England Journal of Medicine, 2005
- News Feature: A crucial testNature Medicine, 2005
- Argon Laser Photocoagulation–Induced Modification of Gene Expression in the RetinaInvestigative Ophthalmology & Visual Science, 2003
- Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy.Seminars in Ophthalmology, 2001